Medeon Biodesign Receives FDA 510(k) Clearance for Abclose - Laparoscopic Port Site Closure Device

News AbClose is designed to reduce time, cost, and risk of port site closure and minimize the frustrations experienced by surgical teams at the end of the surgical procedure. Contributed Author:  Medeon Biodesign Topics:  Surgical